KCAS Bio
Ryan Darling is the Associate Director of Mass Spectrometry Bioanalysis at KCAS Bio, bringing over 13 years of experience in the pharmaceutical and CRO industries. His expertise lies in LC-MS method development across a wide range of modalities, including small molecules, proteins, and oligonucleotides, with a particular emphasis on the bioanalysis of antibody-drug conjugates (ADCs) and antibody-RNA conjugates (ARCs). Throughout his career, Ryan has been dedicated to advancing bioanalytical strategies to support complex drug development programs, combining technical innovation with a deep understanding of regulated bioanalysis environments.